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Okayama University research: Fourth key molecule identified in bone development  
 
(Okayama, 16 February) Researchers at Okayama University have identified the role of an 
additional protein in controlling the signalling processes for bone repair and growth. 
 
Bone repair and remodelling is achieved by the resorption of bone tissue by cells called 
‘osteoclasts’ and the generation of new bone material by ‘osteoblasts’. Previous research 
had suggested that the molecular signalling for the generation of osteoclasts relies on a trio 
of protein molecules: RANK, RANKL and OPG. Now results from researchers at Okayama 
University have identified the crucial contribution of a fourth protein in the process.  
 
RANK is a membrane protein that is essential in the generation of osteoclasts. It is regulated 
by a RANK ligand (RANKL) and the protein OPG, which acts as a decoy receptor inhibiting 
RANK signalling. 
 
Masaharu Takigawa and colleagues at Okayama University Dental School and Okayama 
University Graduate School of Medicine and Pharmaceutical Science focused their 
investigations on the secreted protein CCN2. Previous work had already suggested that 
CCN2 plays a multifunctional role on various skeletal cells. “However,” as the researchers 
explain in the report of their studies, “The precise mechanisms of CCN2 action in the 
RANK/RANKL/OPG system were not sufficiently elucidated, though the system is known as 
crucial in osteoclast differentiation.” 
 
The researchers sought peptides that bind to CCN2 through bacteriophage display screening 
and identified RANK. They then used a range of techniques to pin down CCN2 activity in cells, 
such as binding behaviour and the translocation of factors in the cells. 
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The researchers found that CCN2 binds to RANK and enhanced RANK signalling in the 
generation of osteoclast cells. They also found that CCN2 binds to OPG, an interaction that 
impinges on the binding of CCN2 to RANK, but also prevents OPG inhibiting RANK signalling. 
 
In their report of the work Takigawa and his colleagues conclude, “Therefore we propose 
CCN2 as a candidate of the fourth key molecule working in RANK/RANKL/OPG.” 
 
Background 
Osteoclastogenesis  
NF-kappa B (nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein 
complex that controls transcription of DNA, and is integral in a range of processes. It is 
widely understood that NF-kappa B plays a crucial role in osteoclastogenesis – the 
generation of osteoclasts. Previous work has indicated that osteoclast cells mature by 
means of receptor activator of NF-kappa B (RANK) signalling. The factors JNK and p38 are 
also understood to mediate RANK signalling. 
 
Prior studies had also highlighted two mechanisms that regulate RANK signalling. The RANK 
ligand (RANKL) binds to RANK, activating factors NF-kappa B and JNK to trigger 
differentiation of cells into specialised osteoclasts. The other regulator, osteoprotegerin 
(OPG) inhibits the signalling by binding to RANK instead. 
 
CCN2 
The acronym CCN describes a family of secreted proteins that are rich in the amino acid 
cysteine. Although the family now includes a total of six proteins, the acronym stems from 
the initials of the three founder members: cysteine-rich 61 (CCN1), connective tissue 
regrowth factor (CCN2 – the focus of the current research) and nephroblastoma 
overexpressed (CNN3). 
 
The secreted protein CCN2 binds to a variety of cytokines, membrane proteins and 
extracellular matrix components, prompting the Takigawa and colleagues to explore its 
possible biological functions. They used ‘bacteriophage display screening’ to search for 
peptides binding to CCN2 and identified an amino acid sequence homologous to RANK. 
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Studies of CCN2 in cultured mouse cells revealed several functions that are important in 
osteoclastogenesis. It enhances the translocation of NF-kappa B from the cell cytoplasm to 
the nucleus. It also enhances the phosphorylation of p38 and JNK – a process that involves 
the addition of a phosphate group and is known to control protein activity. In addition it 
inhibits activity of the OPG regulator by binding to it. 
 
Experiments 
The investigation of CCN2 activity included assays to monitor the binding between proteins, 
as well as surface plasmon resonance measurements to analyse the strength of the binding. 
Staining NF-kappa B allowed the researchers to assess the rate of its translocation by 
comparing signal intensities in the cytosol and the nucleus of cells.  
 
Mitogen-activated protein kinases (MAPK) are protein enzymes that catalyse the transfer of 
phosphates. The researchers used western blotting to monitor RANK signalling via MAPK in 
the presence and absence of CCN2. In addition they used polymerase chain reaction (PCR) 
analysis to monitor osteoclast differentiation markers when stimulated by RANKL with and 
without CCN2. These tests also confirmed that CCN2 amplifies RANK signalling. 
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Figure caption  
Amplification of p38 and JNK activation induced by RANKL stimulation of RAW264.7 
(cultured mouse cells) by CCN2. RAW264.7 cells (6.6× 104/well) were plated overnight, and 
the culture medium was changed to 1% FCS/αΜΕΜ. The next day, the cells were stimulated 
with RANKL-GST (25 ng/ml) in the presence or absence of CCN2 (100 ng/ml). After 
incubation for the indicated times, the cells were collected in RIPA buffer. The lysate was 
analyzed by Western blotting using anti-MAPK antibodies. Data are representative of those 
of 3 independent experiments. 
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Okayama University Medical Research Updates （OU-MRU） 
Vol.1：Innovative non-invasive ‘liquid biopsy’ method to capture circulating tumor cells 
from blood samples for genetic testing 
Vol.2：Ensuring a cool recovery from cardiac arrest 
Vol.3：Organ regeneration research leaps forward 
Vol.4：Cardiac mechanosensitive integrator 
Vol.5：Cell injections get to the heart of congenital defects 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
About Okayama University 
Okayama University is one of the largest 
comprehensive universities in Japan with 
roots going back to the Medical Training  
Place sponsored by the Lord of Okayama  
and established in 1870. Now with 1,300 
faculty and 14,000 students, the University 
offers courses in specialties ranging from 
medicine and pharmacy to humanit ies  
a n d  p h y s i c a l  s c i e n c e s .  O k a y a m a  
University is located in the heart of Japan 
approximately 3 hours west of Tokyo by  
Shinkansen. 
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